Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts

被引:5
作者
Peek, Niels [1 ,2 ]
Hindricks, Gerhard [3 ,4 ]
Akbarov, Artur [1 ]
Tijssen, Jan G. P. [5 ]
Jenkins, David A. [1 ]
Kapacee, Zoher [1 ]
Parkes, Le Mai [1 ]
van der Geest, Rob J. [6 ]
Longato, Enrico [7 ]
Sprague, Daniel [8 ]
Taleb, Youssef [8 ]
Ong, Marcus [8 ]
Miller, Christopher A. [9 ]
Shamloo, Alireza Sepehri [3 ,4 ]
Albert, Christine [10 ]
Barthel, Petra [11 ]
Boveda, Serge [12 ]
Braunschweig, Frieder [13 ]
Johansen, Jens Brock [14 ]
Cook, Nancy [15 ]
de Chillou, Christian [16 ]
Elders, Petra [17 ]
Faxen, Jonas [18 ]
Friede, Tim [19 ]
Fusini, Laura [20 ]
Gale, Chris P. [21 ]
Jarkovsky, Jiri [22 ]
Jouven, Xavier [23 ]
Junttila, Juhani [24 ,25 ]
Kautzner, Josef [26 ]
Kiviniemi, Antti [24 ,25 ]
Kutyifa, Valentina [27 ]
Leclercq, Christophe [28 ]
Lee, Daniel C. [29 ]
Leigh, Jill [30 ]
Lenarczyk, Radoslaw [31 ]
Leyva, Francisco [32 ]
Maeng, Michael [33 ]
Manca, Andrea [34 ]
Marijon, Eloi [35 ]
Marschall, Ursula [36 ]
Merino, Jose Luis [37 ]
Mont, Lluis [38 ]
Nielsen, Jens Cosedis [33 ,39 ]
Olsen, Thomas [14 ]
Pester, Julie [15 ]
Pontone, Gianluca [20 ]
Roca, Ivo [38 ]
Schmidt, Georg [11 ]
Schwartz, Peter J. [40 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Informat Imaging & Data Sci, Manchester, Lancs, England
[2] Univ Cambridge, Healthcare Improvement Studies Inst THIS Inst, Dept Publ Hlth & Primary Care, Cambridge, England
[3] Deutsch Herzzentrum Charite, Dept Cardiol Angiol & Intens Care Med, Campus Charit Mitte, Charite Pl 1, D-10117 Berlin, Germany
[4] Heart Ctr Leipzig, Dept Electrophysiol, Strumpellstr 39, D-04289 Leipzig, Germany
[5] AMC, Clin Epidemiol & Biostat, Amsterdam, Netherlands
[6] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands
[7] Univ Padua, Dept Informat Engn, Padua, Italy
[8] Spectra Analyt, London, England
[9] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Med Sci, Manchester, Lancs, England
[10] Cedars Sinai Med Ctr, Smidt Heart Inst, Dept Cardiol, Los Angeles, CA USA
[11] Tech Univ Muchen, Klinikum Rechts Isar, Munich, Germany
[12] Clin Pasteur, Cardiol Heart Rhythm Management Dept, Toulouse, France
[13] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
[14] Odense Univ Hosp, Dept Cardiol, Dept Cardiol Odense, Syddanmark, Denmark
[15] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[16] CHRU Nancy, Dept Cardiol, Nancy, Meurthe Moselle, France
[17] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care, Med, Amsterdam, Netherlands
[18] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
[19] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany
[20] Ctr Cardiol Monzino IRCCS, Dept Cardiovasc Imaging, Milan, Italy
[21] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
[22] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic
[23] Georges Pompidou European Hosp, Med & Surg Dept Cardiol, Paris, France
[24] Univ Oulu, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland
[25] Oulu Univ Hosp, Oulu, Finland
[26] Univ Hosp Olomouc, Inst Clin & Expt Med, Moravia, Czech Republic
[27] Univ Rochester, Clin Cardiovasc Res Ctr, Med Ctr, Rochester, NY USA
[28] CHU Pontchaillou, Serv Cardiol & Malad Vasc, Rennes, France
[29] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[30] Boston Sci Corp, St Paul, MN USA
[31] Med Univ Silesia, Silesian Ctr Heart Dis, Dept Cardiol Congenital Heart Dis & Electrotherap, Div Med Sci Zabrze, Katowice, Poland
[32] Silesian Ctr Heart Dis, Heart Dis & Electrotherapy, Birmingham, W Midlands, England
[33] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[34] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[35] Hop Europeen Georges Pompidou, Div Cardiol, Paris, France
[36] Barmer, Hamburg, Germany
[37] La Paz Univ Hosp, Arrhythmia & Robot Electrophysiol Unit, Madrid, Spain
[38] Univ Barcelona, Hosp Clin, Catalonia, Spain
[39] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[40] IRCCS Ist Auxol Italiano, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy
[41] Univ Basel, Univ Hosp Basel, Dept Cardiol, Basel, Switzerland
[42] Rambam Hlth Care Campus, Dept Cardiol, Haifa, Israel
[43] Olomouc Univ Hosp, Dept Internal Med & Cardiol, Moravia, Czech Republic
[44] Univ Amsterdam, Amsterdam Univ Med Ctr AMC, Dept Clin & Expt Cardiol, Amsterdam, Netherlands
[45] Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark
[46] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany
[47] Albert Einstein Coll Med, Bronx, NY USA
[48] Amsterdam UMC Locat Univ Amsterdam, Dept Cardiol, Amsterdam, Netherlands
[49] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium
[50] Univ Hosp Leuven, Cardiol, Leuven, Belgium
关键词
Implantable cardioverter-defibrillator; Myocardial infarction; Primary prevention; Sudden cardiac death; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; RISK STRATIFICATION; PREDICTION MODELS; HEART-FAILURE; SURVIVAL; BENEFIT; ARREST; SCORE;
D O I
10.1093/eurheartj/ehae326
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aims Risk stratification of sudden cardiac death after myocardial infarction and prevention by defibrillator rely on left ventricular ejection fraction (LVEF). Improved risk stratification across the whole LVEF range is required for decision-making on defibrillator implantation. Methods The analysis pooled 20 data sets with 140 204 post-myocardial infarction patients containing information on demographics, medical history, clinical characteristics, biomarkers, electrocardiography, echocardiography, and cardiac magnetic resonance imaging. Separate analyses were performed in patients (i) carrying a primary prevention cardioverter-defibrillator with LVEF <= 35% [implantable cardioverter-defibrillator (ICD) patients], (ii) without cardioverter-defibrillator with LVEF <= 35% (non-ICD patients <= 35%), and (iii) without cardioverter-defibrillator with LVEF > 35% (non-ICD patients >35%). Primary outcome was sudden cardiac death or, in defibrillator carriers, appropriate defibrillator therapy. Using a competing risk framework and systematic internal-external cross-validation, a model using LVEF only, a multivariable flexible parametric survival model, and a multivariable random forest survival model were developed and externally validated. Predictive performance was assessed by random effect meta-analysis. Results There were 1326 primary outcomes in 7543 ICD patients, 1193 in 25 058 non-ICD patients <= 35%, and 1567 in 107 603 non-ICD patients >35% during mean follow-up of 30.0, 46.5, and 57.6 months, respectively. In these three subgroups, LVEF poorly predicted sudden cardiac death (c-statistics between 0.50 and 0.56). Considering additional parameters did not improve calibration and discrimination, and model generalizability was poor. Conclusions More accurate risk stratification for sudden cardiac death and identification of low-risk individuals with severely reduced LVEF or of high-risk individuals with preserved LVEF was not feasible, neither using LVEF nor using other predictors.
引用
收藏
页码:4616 / 4626
页数:11
相关论文
共 32 条
  • [1] A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
    Ashar, Foram N.
    Mitchell, Rebecca N.
    Albert, Christine M.
    Newton-Cheh, Christopher
    Brody, Jennifer A.
    Mueller-Nurasyid, Martina
    Moes, Anna
    Meitinger, Thomas
    Mak, Angel
    Huikuri, Heikki
    Junttila, M. Juhani
    Goyette, Philippe
    Pulit, Sara L.
    Pazoki, Raha
    Tanck, MichaelW.
    Blom, Marieke T.
    Zhao, XiaoQing
    Havulinna, Aki S.
    Jabbari, Reza
    Glinge, Charlotte
    Tragante, Vinicius
    Escher, Stefan A.
    Chakravarti, Aravinda
    Ehret, Georg
    Coresh, Josef
    Li, Man
    Prineas, Ronald J.
    Franco, Oscar H.
    Kwok, Pui-Yan
    Lumley, Thomas
    Dumas, Florence
    McKnight, Barbara
    Rotter, Jerome I.
    Lemaitre, Rozenn N.
    Heckbert, Susan R.
    O'Donnell, Christopher J.
    Hwang, Shih-Jen
    Tardif, Jean-Claude
    VanDenburgh, Martin
    Uitterlinden, Andre G.
    Hofman, Albert
    Stricker, Bruno H. C.
    de Bakker, Paul I. W.
    Franks, Paul W.
    Jansson, Jan-Hakan
    Asselbergs, Folkert W.
    Halushka, Marc K.
    Maleszewski, Joseph J.
    Tfelt-Hansen, Jacob
    Engstrom, Thomas
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 (44) : 3961 - +
  • [2] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Bardy, GH
    Lee, KL
    Mark, DB
    Poole, JE
    Packer, DL
    Boineau, R
    Domanski, M
    Troutman, C
    Anderson, J
    Johnson, G
    McNulty, SE
    Clapp-Channing, N
    Davidson-Ray, LD
    Fraulo, ES
    Fishbein, DP
    Luceri, RM
    Ip, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 225 - 237
  • [3] Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-Defibrillator
    Barsheshet, Alon
    Moss, Arthur J.
    Huang, David T.
    McNitt, Scott
    Zareba, Wojciech
    Goldenberg, Ilan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (23) : 2075 - 2079
  • [4] Death with an implantable cardioverter-defibrillator: a MADIT-II substudy
    Chernomordik, Fernando
    Jons, Christian
    Klein, Helmut U.
    Kutyifa, Valentina
    Nof, Eyal
    Zareba, Wojciech
    Daubert, James P.
    Greenberg, Henry
    Glikson, Michael
    Goldenberg, Ilan
    Beinart, Roy
    [J]. EUROPACE, 2019, 21 (12): : 1843 - 1850
  • [5] Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.1038/bjc.2014.639, 10.1186/s12916-014-0241-z, 10.1016/j.jclinepi.2014.11.010, 10.1136/bmj.g7594, 10.7326/M14-0697, 10.1002/bjs.9736, 10.7326/M14-0698, 10.1016/j.eururo.2014.11.025]
  • [6] Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
    Curtain, James P.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Petrie, Mark C.
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Bengtsson, Olof
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Solomon, Scott D.
    McMurray, John J., V
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3727 - 3738
  • [7] Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Dagres, Nikolaos
    Hindricks, Gerhard
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (26) : 1964 - 1971A
  • [8] Predictors of sudden cardiac death in high-risk patients following a myocardial infarction
    Docherty, Kieran F.
    Ferreira, Joao Pedro
    Sharma, Abhinav
    Girerd, Nicolas
    Gregson, John
    Duarte, Kevin
    Petrie, Mark C.
    Jhund, Pardeep S.
    Dickstein, Kenneth
    Pfeffer, Marc A.
    Pitt, Bertram
    Rossignol, Patrick
    Zannad, Faiez
    McMurray, John J., V
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 848 - 855
  • [9] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [10] Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
    Gatzoulis, Konstantinos A.
    Tsiachris, Dimitrios
    Arsenos, Petros
    Antoniou, Christos-Konstantinos
    Dilaveris, Polychronis
    Sideris, Skevos
    Kanoupakis, Emmanuel
    Simantirakis, Emmanouil
    Korantzopoulos, Panagiotis
    Goudevenos, Ioannis
    Flevari, Panagiota
    Iliodromitis, Efstathios
    Sideris, Antonios
    Vassilikos, Vassilios
    Fragakis, Nikolaos
    Trachanas, Konstantinos
    Vernardos, Michail
    Konstantinou, Ioannis
    Tsimos, Konstantinos
    Xenogiannis, Iosif
    Vlachos, Konstantinos
    Saplaouras, Athanasios
    Triantafyllou, Konstantinos
    Kallikazaros, Ioannis
    Tousoulis, Dimitrios
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (35) : 2940 - 2949